Spebrutinib
CAS: 1202757-89-8
Ref. TM-T2603
2mg | 41.00 € | ||
5mg | 57.00 € | ||
10mg | 83.00 € | ||
25mg | 97.00 € | ||
50mg | 122.00 € | ||
100mg | 194.00 € | ||
1mL*10mM (DMSO) | 63.00 € |
Product Information
- LMK-435
- CC-292
- AVL-292
- 2-Propenamide, N-[3-[[5-fluoro-2-[[4-(2-methoxyethoxy)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-
- N-[3-[[5-Fluoro-2-[[4-(2-methoxyethoxy)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-2-propenamide
- AVL292
Spebrutinib (LMK-435) is an orally bioavailable, selective inhibitor of Bruton's agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic
Chemical properties
Technical inquiry about: TM-T2603 Spebrutinib
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.